The therapeutic dilemma of inclusion body myositis

Neurology. 1997 Mar;48(3):567-8. doi: 10.1212/wnl.48.3.567.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Autoimmune Diseases / therapy*
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Male
  • Myositis, Inclusion Body / diagnosis
  • Myositis, Inclusion Body / therapy*
  • gamma-Globulins / administration & dosage

Substances

  • Immunoglobulins, Intravenous
  • gamma-Globulins